RGMa Antibodies

Santa Cruz Biotechnology provides a broad selection of RGMa monoclonal antibodies for advanced research in molecular biology. RGMa monoclonal antibodies support multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RGMa, or Repulsive Guidance Molecule a, plays a vital role in neuronal development and regeneration by regulating axon guidance and cell migration. RGMa's involvement in the nervous system makes it a key target for understanding neurodegenerative diseases and potential therapeutic interventions. RGMa has demonstrated significant influence in immune responses and cancer progression, making it relevant for both basic and translational research. Researchers worldwide rely on RGMa monoclonal antibodies to advance their understanding of neurological disorders and potential treatments. RGMa investigation continues to reveal new insights into cellular mechanisms and disease pathways. Santa Cruz Biotechnology monoclonal antibodies for RGMa support researchers in their mission to unlock new discoveries that benefit human health.